GGrantIndex
← Leaderboards

Yuhua Bao

Weill Medical Coll Of Cornell Univ

$5,650,344
Attributed
$9,279,479
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,279,479 · 8

By mechanism

R33$3,350,010 · 1
R01$2,866,719 · 2
RM1$1,328,798 · 1
K01$782,097 · 1
R61$598,795 · 1
P30$215,694 · 1

Most similar at Weill Medical Coll Of Cornell Univ

Same institution · by research overlap

Others in their field

Top investigators on “Caring

Research focus

CaringIncentivesProgramsDesignProviderMedicarePaymentPoliciesDatabasesLinkBasePersonsHealthcareCostEvidence BaseAdoptionResourcesAffectPrimary Health CareEvaluationOverdoseMental HealthFutureEvent

Grant awards (20)

Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME)$1,328,798
RM1 · FY2025 · DA
Leveraging regulatory flexibility for methadone take-home dosing to improve retention in treatment for opioid use disorder: A stepped-wedge randomized trial to facilitate clinic level changes$1,089,537
R33 · FY2025 · DA
Opioid Treatment of Pain in People with Cancer: Intended and unintended consequences of state policies addressing opioid prescribing$387,731
R01 · FY2025 · CA · contact PI
Pilot Grant, Training and Mentoring Core$215,694
P30 · FY2025 · DA · contact PI
Leveraging regulatory flexibility for methadone take-home dosing to improve retention in treatment for opioid use disorder: A stepped-wedge randomized trial to facilitate clinic level changes$1,114,378
R33 · FY2024 · DA
Opioid Treatment of Pain in People with Cancer: Intended and unintended consequences of state policies addressing opioid prescribing$368,346
R01 · FY2024 · CA · contact PI
Leveraging regulatory flexibility for methadone take-home dosing to improve retention in treatment for opioid use disorder: A stepped-wedge randomized trial to facilitate clinic level changes$1,146,095
R33 · FY2023 · DA
Opioid Treatment of Pain in People with Cancer: Intended and unintended consequences of state policies addressing opioid prescribing$379,977
R01 · FY2023 · CA · contact PI
Leveraging regulatory flexibility for methadone take-home dosing to improve retention in treatment for opioid use disorder: A stepped-wedge randomized trial to facilitate clinic level changes$598,795
R61 · FY2022 · DA
Opioid Treatment of Pain in People with Cancer: Intended and unintended consequences of state policies addressing opioid prescribing$387,731
R01 · FY2022 · CA · contact PI
Value-based Purchasing in Implementation of Depression Care in Community Clinics$424,221
R01 · FY2016 · MH · contact PI
Value-based Purchasing in Implementation of Depression Care in Community Clinics$477,159
R01 · FY2015 · MH · contact PI
Value-based Purchasing in Implementation of Depression Care in Community Clinics$441,554
R01 · FY2014 · MH · contact PI
Designing Payment and Performance Evaluation for Depression Care Management$154,913
K01 · FY2014 · MH · contact PI
Designing Payment and Performance Evaluation for Depression Care Management$156,896
K01 · FY2013 · MH · contact PI
Designing Payment and Performance Evaluation for Depression Care Management$159,335
K01 · FY2012 · MH · contact PI
Designing Payment and Performance Evaluation for Depression Care Management$156,924
K01 · FY2011 · MH · contact PI
Designing Payment and Performance Evaluation for Depression Care Management$154,029
K01 · FY2010 · MH · contact PI
Cost of an Evidence Based Depression Care Management Intervention in Home Health$52,907
R03 · FY2010 · MH · contact PI
Cost of an Evidence Based Depression Care Management Intervention in Home Health$84,459
R03 · FY2009 · MH · contact PI